Oh Snap! Add something to your Cart.
Total:
Section27, TAC wade into big pharma bust-up over cancer drug
The TAC and Section 27 have joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent war over cancer drug Docetaxel....
Published By: Mail & Guardian - Wednesday, 16 May, 2012
- Older News
- Drug maker Elan looks to deals as defence
- Phungi Baloyi enjoying life to the fullest
- Cancer can be beaten if it is detected early
- Teen develops dipstick test for cancer
- Calling off drug abuse
- Hydroponic dagga bust in Foxhill
- Cancer drugs, Tamiflu lift Roche quarter sales
- Scottish author Iain Banks has terminal cancer
- India’s top court dismisses plea by Novartis for cancer-drug patent
- Record gene haul could improve cancer screening
- March, 22
- Patent board rules against Bayer in blow for 'big pharma'
- Tech gurus, UK scientists team up to create cancer research game
- Obesity, skin cancer ‘have genetic link’
- Tech gurus to design cancer research game
- Teenager crafts early cancer detection tool - with video
- Teen crafts tool for early cancer detection
- Teenager crafts early detection tool for cancer
- Teenager crafts tool for early cancer detection tool - with video
- Drug 'nyaope' to be made illegal in South Africa